Stryker Corporation $SYK Shares Sold by NS Partners Ltd

NS Partners Ltd lessened its holdings in shares of Stryker Corporation (NYSE:SYK) by 22.3% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 83,396 shares of the medical technology company’s stock after selling 23,868 shares during the period. NS Partners Ltd’s holdings in Stryker were worth $26,256,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. CMH Wealth Management LLC boosted its holdings in shares of Stryker by 8.2% during the second quarter. CMH Wealth Management LLC now owns 18,271 shares of the medical technology company’s stock valued at $5,768,000 after acquiring an additional 1,384 shares during the period. Covington Investment Advisors Inc. increased its stake in shares of Stryker by 3.5% in the second quarter. Covington Investment Advisors Inc. now owns 16,792 shares of the medical technology company’s stock valued at $5,287,000 after purchasing an additional 571 shares during the period. Advocacy Wealth Management LLC boosted its position in Stryker by 24.4% during the 2nd quarter. Advocacy Wealth Management LLC now owns 48,645 shares of the medical technology company’s stock worth $15,315,000 after acquiring an additional 9,551 shares during the period. CTC Alternative Strategies Ltd. acquired a new position in shares of Stryker during the second quarter valued at $227,000. Finally, Quantitative Investment Management LLC bought a new position in Stryker in the 2nd quarter valued at about $1,870,000. Institutional investors own 77.09% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on SYK. Evercore set a $350.00 price target on shares of Stryker in a research note on Monday, July 6th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Stryker in a research note on Friday, July 31st. UBS Group started coverage on shares of Stryker in a research report on Tuesday, July 28th. They issued a “buy” rating and a $400.00 price target on the stock. Raymond James Financial set a $370.00 price objective on shares of Stryker in a research note on Friday, July 31st. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Stryker from $400.00 to $350.00 and set an “overweight” rating for the company in a research note on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, Stryker has an average rating of “Moderate Buy” and a consensus target price of $386.28.

Stryker Trading Down 1.9%

Stryker stock opened at $324.32 on Tuesday. Stryker Corporation has a 12 month low of $281.00 and a 12 month high of $396.86. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The stock has a market cap of $124.40 billion, a P/E ratio of 33.61, a P/E/G ratio of 2.11 and a beta of 0.76. The company’s fifty day simple moving average is $329.49 and its 200-day simple moving average is $331.03.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The business had revenue of $6.59 billion during the quarter, compared to analyst estimates of $6.58 billion. During the same quarter in the previous year, the business earned $3.13 EPS. Stryker’s quarterly revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, sell-side analysts forecast that Stryker Corporation will post 15.02 EPS for the current fiscal year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s dividend payout ratio is presently 36.48%.

Insider Activity

In other Stryker news, insider Debra King sold 826 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the completion of the transaction, the insider owned 6,210 shares of the company’s stock, valued at $2,088,423. This represents a 11.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Dylan Bram Crotty sold 441 shares of Stryker stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $328.61, for a total value of $144,917.01. Following the sale, the insider directly owned 6,102 shares in the company, valued at $2,005,178.22. The trade was a 6.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 351,267 shares of company stock valued at $118,197,701. Insiders own 4.60% of the company’s stock.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.